Introduction
The 22q13.3 deletion syndrome, also known as PhelanMcDermid syndrome, is a genetic disorder characterized by global developmental delay, hypotonia, delayed or absent speech, and autistic behaviour. 1, 2 Haploinsufficiency of SHANK3 (SH3 and multiple ankyrin repeat domains 3) gene is considered likely the cause of some of the neurological conditions in this syndrome. SHANK3 gene codifies for a master scaffolding protein that forms a key framework in the postsynaptic density of glutamatergic synapses and plays a critical role in synaptic function, learning and memory. 3 However the deletion of additional genes in subjects with larger deletions may lead to more complex phenotypes. 2, [4] [5] [6] [7] Clinical signs are rather non-specific and the clinical phenotype is extremely variable. Neurologic problems include seizures which have been reported in up to one third of the patients.
1,2,4-15
Here we describe six unrelated patients with 22q13.3 deletion syndrome. They show a similar typical phenotype also characterized by seizures and/or EEG focal or multifocal paroxysmal abnormalities.
Retardation and Brain Aging, Troina, Italy; Department of Neurology, Federico II University of Naples, Naples, Italy). They were selected for genome-wide CGH array upon a history of mental retardation, dysmorphic features, seizures and/or EEG abnormalities.
All the subjects underwent a complete general and neurologic examinations. The EEG study consisted of at least one awake and one nap-sleep video-EEG recordings and evaluation of other EEGs performed elsewhere. All patients underwent brain MRI.
Patient 1
This is a 23 years old girl, born from unrelated parents. Her father is affected by osteogenesis imperfecta type 1. Family history is negative for epilepsy or other neurological conditions. She was born at term after an uneventful pregnancy. Growth parameters were approximately at the 50th centile. At birth she was floppy and her psychomotor development was delayed: she walked independently at about 4 years and produced her first words at the age of 7. Following repetitive bone traumas due to falls, at the age of 7 she was diagnosed with osteogenesis imperfecta type 1. At the age of 10 she presented with brief and rare episodes of generalized myoclonias without loss of consciousness. She was started on lamotrigine with poor success. Seizures continued over the next years with monthly episodes characterized by loss of consciousness, eyes rolled to the back, upper arms myoclonias, post-ictal sleep. Seizures were not timely related to any regression in psychomotor abilities. At the age of 15 they settled for about a year, apparently independently from drug treatment. She came to our attention at the age of 20 when she was still suffering from myoclonic seizures with a frequency of 3-4 per month and rare episodes of absences. She was under treatment with lamotrigine (350 mg/die). At that time physical examination showed growth parameters at the 25th percentile, facial dysmorphisms (elongated face, mandibular prolapse) (see Fig. 1a ), scoliosis, bilateral genu valgum, large and flashy hands. She was also diagnosed with mitral prolapse. The neurological examination showed moderate intellectual disability, autistic traits, generalized brisk tendon reflexes and hypotrofic calves. Her language was very poor with frequent echolalia. A brain MRI showed a cyst of the septum pellucidum and cavum vergae. The awake EEG showed multifocal spike and wave discharges, mainly represented over the left frontal areas (Fig. 2a) . These were not accompanied by clinical manifestations. Sleep increased EEG paroxysmal abnormalities. She was started on valproate that was soon after interrupted as not tolerated. She is now presenting with very rare episodes of absences and is under treatment with lamotrigine 350 mg/die.
Array-CGH was performed using the Agilent Human Genome CGH Microarray Kit 44B (Agilent, CA, USA) with a resolution of 75 Kb. This revealed a 4.6 MB deletion at 22q13.2-13.31 (Chr22:42,385,962-46,988,921; HG19), which was confirmed through FISH analysis (BAC probes bA790J21).
Patient 2
This is a 30 years old woman born from healthy, unrelated parents. Family history is negative for epilepsy and other neurological conditions. She was born at term after an uneventful pregnancy. At 9 months she was diagnosed with b haemolytic streptococcus meningitis. From that time on she was noted to have a psychomotor delay. At 1 year of age her cranial circumference (CC) was 43 cm (below 3rd centile), her growth parameters were set at the 25th centile, she was hypotonic, unable to sit or crawl. From 18 months of age autistic features were noted. She walked independently at the age of 4 and language appeared at the age of 7 but this has always been very poor.
She presented with the first seizure at the age of 3 during a febrile illness: she vomited, lost her consciousness, became hypotonic, then myoclonias appeared over her right eyelid and lip, rapidly spreading to the upper and lower arm of the same side. She was started on valproate (480 mg/die) and did not present further episodes until the age of 5 when a similar but shorter afebrile episode occurred. At the age of 10 she discontinued the treatment as no other episodes occurred, but a year later she developed a myoclonic status that required intravenous benzodiazepines. She was then trialled on carbamazepine and vigabatrin. At the age of 13 she discontinued again the treatment and did not present any episode for 10 years. Seizures reappeared at the age of 23 characterized by clumsy gait, hypersalivation, irregular myoclonic movements of the upper arms. The episodes were long but rare and only PRN diazepam treatment was administered at the beginning. Then she was started on carbamazepine (600 mg/ die) and later lamotrigine (50 mg/die) was added on. Seizures were not correlated to a psychomotor regression.
The patient came to our attention at the age of 25. She was still suffering from prolonged but rare episodes mainly characterized by generalized myoclonic jerks. Lamotrigine was stopped and topiramate was introduced but soon after discontinued as not tolerated. Her physical examination showed facial dysmorphism (see Fig. 1b ), namely elongated face, prominent nose, microcephaly (CC 50 cm, <3rd percentile), large and flashy hands, bilateral genu valgum. Her neurological examination showed moderate intellectual disability, poor language and generalized hypotonia. The awake EEG showed sharp waves over the left temporal regions intermixed with rare high amplitude multifocal sharp waves (Fig. 2b) . Sleep activated EEG paroxysmal abnormalities. The brain MRI showed left temporal atrophy, bilateral dilation of the occipital horns of the lateral ventricles, signal abnormality of the occipital white matter.
Notwithstanding treatment with carbamazepine 600 mg/die the patient continues to present with yearly episodes.
Array-CGH was performed using the Agilent Human Genome CGH Microarray Kit 44B (Agilent, CA, USA) with a resolution of 75 Kb. This revealed a 7.5 MB deletion at 22q13.2-qter (Chr22:43,827,346-51,178,264; HG19), which was confirmed through FISH analysis (chromofobe multiprobe T). 
Patient 3
This 16-year old girl is the second child of unrelated parents. Pregnancy was complicated by reduced foetal movements. Her birth weight at term was 3550 g (50th-75th centile), her length was 52 cm (50th centile) and her head circumference was 34 cm (50th centile). Cyanosis and jaundice were present at birth.
Muscular hypotonia was evident since the neonatal period. She achieved head control at 4 months, crawled at 12 months and started to walk at 14 months. A severe language impairment was present: poor vocalizations and babbling in the first year of life and a vocabulary limited to few words afterwards. At the age of 4, after speech therapy, there was only a little improvement of her language skills and receptive language exceeded the expressive language skills. Afterward, her language regressed until a complete loss. At the age of 16 she also lost her sphincter control.
Her growth parameters were within the inferior limits: weight and height below the 3rd percentile and cranial circumference at the 25th percentile. Dysmorphic features were observed, such as plagiocephaly, narrow forehead, upslanted palpebral fissures, anteverted ears. Among the behavioural issues, she presented, especially in the first years of life, hyperactivity, aggression, oppositional behaviour, sleep disturbances and autistic-like features, such as reduced social interaction, picacism, food selectivity, stereotyped movements, echolalia.
At 8 years old her mental age was estimated at 3 years (severe intellectual disability). The neurological examination showed only gait instability and motor clumsiness. She never suffered from seizures.
The brain MRI showed asymmetry of the lateral ventricles (right > left) and signal abnormality of the occipital periventricular white matter; an EEG recording, performed at the age of 3, showed sharp waves and spike-and-wave complexes localized over the left frontal-central regions, more frequent and diffuse to the contralateral hemisphere during sleep; an EEG performed at age 6 was normal. In this patient (P38 previously published in Bonaglia et al.
2 )
array-CGH revealed a 25 
Patient 4
This 23 years old girl was the second child of unrelated parents. Prenatal history was unremarkable. Her birth weight at term was 3200 g (50th centile), her length was 50 cm (25th-50th centile) and the head circumference was 33 cm (25th centile). Weak crying, cyanosis and hypotonia were present at birth. The motor development was normal, but the language development was delayed with appearance of the first words at the age of 3. In the following years, she developed an unintelligible speech and a comprehension limited to simple sentences. She achieved sphincter control at the age of 5 and lost it at the age of 10. At that time neuropsychological testing showed severe intellectual disability. Among the behavioural issues she presented hyperactivity, aggression, oppositional behaviour, compulsive search of food and sleep disturbances. Dysmorphic features were observed, such as plagiocephaly, anteverted ears, pointed chin, large forehead, asymmetrical face, winged scapulae, lumbar hyperlordosis, bilateral genu valgum, flat feet, two café -aulait spots over the trunk skin and widespread joint hyperlaxity. Neurological examination was normal, except for the presence of clumsiness. She never had seizures, but at age of 8 an EEG showed paroxysmal activity over the frontal-temporal regions, which worsened during sleep ( Fig. 2c and d) . At the age of 15 her EEG was normal. Brain MRI was also normal.
In this patient (P37 previously published in Bonaglia et al. 
Patient 5
This 11-year old boy was the first child of unrelated parents. Prenatal history was characterized by intrauterine growth delay; he was born at term, small for gestational age (weight: 1700 g, <3rd centile; length was 48 cm, <3rd centile; head circumference was 30.5 cm, <3rd centile). At 3 months he underwent surgery for inguinal hernia. Muscle hypotonia was present since the first month of life. Motor development was delayed and expressive language was limited to vocalizations for long time. Neuropsychological testing showed a severe intellectual disability. He presented with hyperactivity, aggression and oppositional behaviour since the first years of life. Dysmorphic features were noted including plagiocephaly, low hairline, arched palate (see Fig. 1c ), joint hyperlaxity, winged scapulae and flat feet. The neurological examination showed muscle hypotonia, lack of motor coordination and clumsiness. He never suffered from seizures but his EEG showed multifocal paroxysmal activity, such as spike and spike-and-wave complexes, over the frontal-temporal regions, which were more pronounced during sleep (Fig. 2e and f) . The brain MRI showed mild frontal atrophy.
In this patient (P23 previously published in Bonaglia et al. 
Patient 6
This 14-year old girl is the first child of unrelated parents. Her father presented with febrile seizures during infancy. She was born at term by caesarean section because of acute foetal distress. Her birth weight was 3100 g (10th centile), her length was 51 cm (10th centile) and her head circumference was 34 cm (25th-50th centile). Cyanosis was present at birth. Motor and language development was delayed. From the age of 2 until the age of 7, she suffered from generalized tonic-clonic seizures occurring yearly, which were not related to regression in abilities. She was treated with carbamazepine (CBZ) 600 mg/day, valproic acid (VPA) 700 mg/day and, shortly with levetiracetam (LEV) 750 mg/day. EEG showed multifocal paroxysmal activity, such as spikes, prevalent over the frontal-temporal regions, which were more pronounced during sleep ( Fig. 2g and h) . Neuropsychological testing showed a severe intellectual disability and expressive language was absent at the age of 7. She also presented with hyperactivity, oppositional behaviour and bruxism. Physical examination revealed diffuse hypotonia, relative microcephaly (head circumference at the 35th centile, height at the 75th centile); no other relevant dysmorphism were present (see Fig. 1d ). Neurological examination showed lack of motor coordination and clumsiness. The brain MRI showed thinning of the corpus callosum (between the body and the splenium), widespread cortical atrophy and dilation of the lateral ventricles, mild widespread reduction of the white matter, mildly dilated perimesencephalic and ambient cisterns. In this patient (P24 previously published in Bonaglia et al.
array-CGH revealed a 1. 
Genetic analysis
Genome-wide array CGH analysis was carried out using the Human Genome CGH Microarray (44B kit, 244A kit, Agilent Technologies, Palo Alto, CA, USA) on all the patients according to the manufacturer's instructions.
In each patient, array-CGH analysis disclosed a deletion of the chromosomal region 22q13.3. No other chromosomal rearrangements were detected. The deletions had a size ranging between 25 Kb and 7.5 Mb and included a variable number of protein coding genes ranging from 1 (case 4) to 70 (case 2). All but case 1 encompassed the SHANK3 gene.
Subsequent FISH experiments performed on the patients and their parents using different probes confirmed the deletions. The deletions occurred as de novo events for patients 2, 3, 4, 5 and 6. Only the mother of patient 1 was available for testing, and she resulted negative. A schematic of all the rearrangements is reported in Fig. 3 .
Discussion and conclusions
We report the presence of a typical EEG pattern, in a group of six patients with 22q13.3 deletion syndrome, characterized by multifocal paroxysmal abnormalities, prevalent over the frontalcentral or frontal-temporal regions, with a clear sleep activation. This EEG trait is associated with epilepsy in 3 cases; when present epilepsy onset occurs during childhood, with myoclonic or generalized tonic-clonic seizures, and has a rather benign course.
The present study confirms the presence of epilepsy in the 22q13.3 deletion syndrome, as described in the literature.
1,2,4-15 In 22q13.3 deletion syndrome patients, seizures typically develop around puberty, although younger children can be affected. They may present as febrile or afebrile generalized tonic-clonic, focal, and absence seizures. No characteristic EEG findings have been associated with 22q13.3 deletion syndrome so far. Although genotype-phenotype correlation analyses in 22q13.3 deletion syndrome show that larger deletions are associated with increased levels of dysmorphic features and medical comorbidities, seizures have not been correlated with the deletion size. [4] [5] [6] 10 On the other hand, analyses of subjects with small deletions or SHANK3 point mutations allowed to identify correlations with seizures and abnormal EEG. 6 More than 90 genes may be deleted in the 22q13.3 deletion syndrome. In our series the number of involved genes is variable from 1 to 70. Among the genes included in this region, literature data on mice with SHANK3 knockdown report SHANK3 as the candidate gene for some of the neurological features typical of 22q13.3 deletion syndrome, such as autism and intellectual disability. This gene codifies for a scaffolding protein, which lies within the postsynaptic density (PSD) of the excitatory glutamatergic synapses. 16 In cultured mouse neurons, a change in SHANK3 expression leads to abnormalities of spine density and function. RNA interference-mediated knockdown of SHANK3 resulted in decreased dendritic spine density in hippocampal neurons, while transgenic overexpression induced the growth of spines in aspiny cerebellar neurons and led to increased synaptic contacts and increased spine size. 17 The potential role of SHANK3 gene in epileptogenesis is far to be understood since SHANK3 knockdown mice do not show seizures or EEG abnormalities. However, dendritic spine abnormalities may promote hyperexcitable circuits and seizures in some specific genetic syndromes with documented dendritic pathology, such as Rett syndrome, tuberous sclerosis, fragile X syndrome, Down's syndrome. 18 In our series cases 2, 3, 4, 5 and 6 had a deletion encompassing SHANK3. Although all of them showed EEG abnormalities only cases 2 and 6 had epilepsy. Case 1 suffered from epilepsy as well, but her deletion did not encompass SHANK3. Furthermore case 4, whose deletion only involved SHANK3, showed only EEG abnormalities and never suffered from seizures. Other genes with a function within the central nervous system might be involved in the pathogenesis of epilepsy for this condition or at least contribute to the resulting phenotype.
Among the genes shared between case 1 and 2, five genes might play a role as they are highly expressed in the brain or have a specific neuronal function: MPPED1 (metallophosphoesterase domain containing 1); SULT4A1 (sulfotransferase family 4A, member 1), NUP50 (nucleoporin 50 kDa), WNT7B (wingless-type MMTV integration site family, member 7B), CELSR1 (cadherin, EGF LAG seven-pass G-type receptor 1). Among the genes shared between case 2 and 6, other eight genes (beyond SHANK3) might play a role as well: ALG12 (alpha-1,6-mannosyltransferase), MLC1 (megalencephalic leukoencephalopathy with subcortical cysts 1), PANX2 (pannexin 2), TUBGCP6 (tubulin, gamma complex associated protein 6), PLXNB2 (plexin B2), SCO2 (cytochrome c oxidase assembly protein), TYMP (thymidine phosphorylase), ARSA (arylsulfatase A). Many of these genes play a role in brain development, and could indirectly promote epileptogenesis or developmental disabilities in 22q13.3 deletion syndrome. Unfortunately, most of the mouse knockdown and in vitro data available for them do not demonstrate seizures or EEG specific phenotypes. In addition, other factors, such as environment, or epigenetic factors, may play important roles in determining seizures or EEG abnormalities in the 22q13.3 deletion syndrome.
Although no characteristic EEG findings have been associated with 22q13 deletion syndrome, not all the patients reported in literature underwent an EEG examination. EEG features in 22q13.3 deletion syndrome have been only sporadically reported. Herman et al. 9 reported a boy aged 3½ months, evaluated for episodes of eye and head deviation to the left suspected to be seizures; an EEG showed a right occipital focus of high voltage polymorphic delta activity. Tabolacci et al. 19 described a 13-year-old boy who never had seizures, but had an EEG showing focal abnormalities during sleep. Another 5-year-old boy has been described as suffering from intermittent seizures, not better specified, occurring since the age of 3 and presenting with spikes and polyspikes arising from the left frontal region on an EEG recording. 20 Bonaglia et al. 2 reported an adult girl with a 8.1 Mb deletion who experienced her first epileptic seizure at the age of 3; her EEG showed abnormal focal electric activity. Her second seizure occurred at the age of 34 years. At the age of 39, epileptic seizures became more frequent and drug-resistant; the EEG recording at that time showed low amplitude, dysrythmic and slow electric activity. More recently, Soorya et al. 6 reported 13/32 patients with 22q13.3 deletion syndrome (41%) with clinical seizures, including 7 with febrile seizures only (22%), 4 (13%) with non-febrile seizures and 2 (6%) with both febrile and non-febrile seizures. Among the patients with non-febrile seizures, five out of six (83%) had generalized seizures and one (17%) had partial complex seizures; all patients with non-febrile seizures had evidence of EEG abnormalities, not specified in detail. One patient underwent temporal lobectomy due to uncontrolled seizure disorder. Four patients (13%) had abnormal, not further specified, EEG recordings without reported seizures.
Central-temporal spikes, may occur in 2-3% of normal schoolage children and in a variety of organic brain diseases and syndromes, with or without seizures, such as fragile X syndrome or 47,XYY karyotype. 21, 22 In our sample of patients with 22q13.3 deletion syndrome there is no evidence of a relationship between seizures or EEG abnormalities and developmental impairment. We also found different and aspecific MRI brain abnormalities in our group of patients confirming previous neuroimaging data, such as reduced myelination, agenesia or thinning of corpus callosum, cerebral ventricle dilation, cortical atrophy. 6, 19, 20, [23] [24] [25] In our series we did not find cerebellar and posterior fossa malformations, namely cerebellar vermis hypoplasia or ''mega cisterna magna'', which were observed in 8/10 patients described by Aldinger et al. 25 These authors propose PLXNB2 and MAPK8IP2
genes, two genes located in the 22q13 region, as candidates for cerebellar phenotypes. PLXNB2 and MAPK8IP2 genes are expressed in the mouse hindbrain and abnormal phenotypes of the developing cerebellum are observed in homozygous mutants for each gene. 26, 27 Further clinical and EEG studies on larger samples of patients with 22q13.3 deletion syndrome are needed to better clarify if a specific EEG pattern and epilepsy profile exist. In fact, our sample is rather small and presumably not representative of the larger population with 22q13.3 deletion syndrome. Serial EEG studies from infancy to adulthood should also be conducted, in order to verify possible electrographic pattern changes throughout life. As some of these patients have EEG abnormalities while do not show clinical seizures, we recommend to carry out routine sleep EEG recordings in all the subjects bearing this deletion. Furthermore, since cerebral and cerebellar abnormalities are rather commonly found, brain MRI is strongly recommended in patients with 22q13.3 deletion syndrome.
